Attached files

file filename
EX-32.2 - CERTIFICATION - Veritas Farms, Inc.f10q0321ex32-2_veritasfarms.htm
EX-32.1 - CERTIFICATION - Veritas Farms, Inc.f10q0321ex32-1_veritasfarms.htm
EX-31.2 - CERTIFICATION - Veritas Farms, Inc.f10q0321ex31-2_veritasfarms.htm
EX-31.1 - CERTIFICATION - Veritas Farms, Inc.f10q0321ex31-1_veritasfarms.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Veritas Farms, Inc.f10q0321ex23-1_veritasfarms.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____________ to _____________

 

Commission File Number: 333-235300

 

Veritas Farms, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   90-1254190
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

1512 E. Broward Blvd., Suite 300, Fort Lauderdale, FL 33301

(Address of principal executive offices, including zip code)

 

(833) 691-4367

(Registrant’s telephone number, including area code)

 

No Changes

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒      No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (ss.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
None        

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer Accelerated Filer 
Non-accelerated Filer Smaller reporting company 
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐      No ☒

 

The number of shares outstanding of the registrant’s common stock, $0.001 par value, as of May 14, 2021 was 46,184,977 shares.

 

 

 

 

 

 

VERITAS FARMS, INC

Quarterly Report on Form 10-Q for the three month period ended March 31, 2021

TABLE OF CONTENTS

 

    Page
PART I – FINANCIAL INFORMATION 1
     
Item 1. Financial Statements (unaudited) 1
  Condensed Consolidated Balance Sheets as of March 31, 2021 and December 31, 2020 1
  Condensed Consolidated Statements of Operations for the three months ended March 31, 2021 and 2020 2
  Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2021 and 2020 3
  Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2021 and 2020 4
  Notes to Condensed Consolidated Financial Statements 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 15
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 20
     
Item 4. Controls and Procedures 20
     
PART II - OTHER INFORMATION 21
     
Item 1. Legal Proceedings 21
     
Item 1A. Risk Factors 21
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 21
     
Item 3. Defaults Upon Senior Securities 21
     
Item 4. Mine Safety Disclosures 21
     
Item 5. Other information 21
     
Item 6. Exhibits 22
     
SIGNATURES 23

 

i

 

 

PART I – FINANCIAL INFORMATION 

 

Item 1 Financial Statements

 

Veritas Farms, Inc. and Subsidiary

Condensed Consolidated Balance Sheets

(Unaudited)

 

   March 31,
2021
   December 31,
2020
 
      (Audited) 
ASSETS        
CURRENT ASSETS        
Cash  $91,980   $107,693 
Inventories   5,788,338    5,891,983 
Accounts Receivable   530,468    386,379 
Prepaid Expenses   256,132    270,557 
Total Current Assets   6,666,918    6,656,612 
           
PROPERTY PLANT AND EQUIPMENT, net of accumulated depreciation of $1,612,153 and $1,483,736 respectively   4,365,953    4,494,370 
           
Intellectual Property   55,000    55,000 
Right of Use Assets, net of accumulated amortization   200,080    930,826 
Deposits   80,393    271,213 
           
TOTAL ASSETS  $11,368,344   $12,408,021 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts Payable  $2,081,790   $2,020,605 
Accrued Expenses   295,241    414,777 
Accrued Interest, non related parties   21,556    13,677 
Convertible Notes Payable, net of discount of $-0- and $23,750 respectively   200,000    176,250 
Deferred Revenue   17,157    16,256 
Operating Lease Liability, current portion   86,253    240,324 
PPP Loan, current portion   1,607,988    803,994 
Long Term Debt, current portion   67,996    66,080 
Total Current Liabilities   4,377,981    3,751,963 
           
LONG-TERM LIABILITIES          
Long-term Debt, net of current portion   259,611    278,527 
Operating Lease Liability, net of current portion   97,737    730,164 
Total Liabilities   4,735,329    4,760,654 
           
STOCKHOLDERS’ EQUITY          
Common Stock, $0.001 par value, 200,000,000 shares authorized, 46,184,977 and 45,784,977 shares issued and outstanding at March 31, 2021 and December 31, 2020 respectively   46,185    45,785 
Additional Paid in Capital   34,408,635    34,268,729 
Accumulated Deficit   (27,821,806)   (26,667,147)
Total Stockholders’ Equity   6,633,015    7,647,367 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $11,368,344   $12,408,021 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

1

 

 

Veritas Farms, Inc. and Subsidiary

Condensed Consolidated Statements of Operations

(Unaudited)

 

   Three Months Ended
March 31
   Three Months Ended
March 31
 
   2021   2020 
Sales  $888,261   $1,154,311 
           
Cost of Sales   601,428    676,698 
Gross profit   286,833    477,613 
           
Operating Expenses          
Selling, General and Administrative   1,166,946    2,795,818 
Total Operating Expenses   1,166,946    2,795,818 
Operating Loss   (880,113)   (2,318,205)
           
Other Expenses          
    Loss on Lease Termination   244,840    - 
Interest Expense – Related Party   -    1,644 
Interest Expense – Non Related Party   29,706    5,420 
Total Other Expenses   274,546    7,064 
Loss before Provision for Income Taxes   (1,154,659)   (2,325,269)
Income Tax Provision   -    - 
Net Loss   (1,154,659)   (2,325,269)
           
Net Loss per Share, Basic and Diluted  $(0.03)  $(0.06)
Weighted Average Shares Outstanding, Basic and Diluted   45,836,802    41,549,431 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

2

 

 

Veritas Farms, Inc. and Subsidiary
Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)

 

   Common Stock   Additional Paid in   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance, December 31, 2020   45,784,977   $45,785   $34,268,729   $(26,667,147)  $7,647,367 
                          
Issuance of Common Stock for Cash   400,000    400    86,495    -    86,895 
                          
Stock-based Compensation   -    -    53,412    -    53,412 
                          
Net Loss   -    -    -    (1,154,659)   (1,154,659)
                          
Balance, March 31, 2021   46,184,977    46,185    34,408,636    (27,821,806)   6,633,015 

 

   Common Stock   Additional Paid in   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance, December 31, 2019   41,421,698   $41,422   $31,228,397   $(19,074,608)  $12,195,212 
                          
Stock-based Compensation   -    -    472,726    -    472,726 
                          
Warrants Exercised   153,279    153    (153)   -    - 
                          
Net Loss   -    -    -    (2,325,269)   (2,325,269)
                          
Balance, March 31, 2020   45,784,977   $41,575   $31,700,970   $(21,399,877)  $10,342,669 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

3

 

 

Veritas Farms, Inc. and Subsidiary
Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   3 Months Ended March 31 
   2021   2020 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net Loss  $(1,154,659)  $(2,325,269)
Adjustments to Reconcile Net Loss to Net Cash Used Operating Activities          
Depreciation   128,417    128,658 
Stock-based Compensation   53,412    472,726 
Changes in Operating Assets and Liabilities          
Inventories   103,646    (62,138)
Prepaid Expenses   14,425    289,384 
Accounts Receivable   (143,186)   40,949 
Deposits   190,820    10,983 
Deferred Revenue   -    15,559 
Accrued Interest, non related parties   7,879    - 
Net change in Operating Lease Assets and Liabilities   (55,753)   (20,122)
Accrued Expenses   (119,535)   56,461 
Accounts Payable   61,184    309,238 
NET CASH USED IN OPERATING ACTIVITIES   (913,352)   (1,046,222)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchase of Property and Equipment   -    (77,423)
NET CASH USED IN INVESTING ACTIVITIES   -    (77,423)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Payments of Long-term Debt   (16,999)   (16,999)
Notes Payable   -    201,644 
Proceeds from Note Payable   827,744    - 
Proceeds from Issuance of Common Stock   86,895    - 
NET CASH PROVIDED BY FINANCING ACTIVITIES   897,640    184,645 
           
NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS   (15,712)   (939,000)
CASH AND CASH EQUIVALENTS - Beginning of Period   107,693    1,076,543 
CASH AND CASH EQUIVALENTS - End of Period  $91,980   $137,543 
           
Supplemental Disclosure of Cash Flow Information:          
Cash Paid for Interest  $-   $3,675 
Non-Cash Transactions          
Operating Lease Right of Use Asset Obtained in Exchange for Lease Obligations  $

160,476

   $1,049,067 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

4

 

 

Veritas Farms, Inc. and Subsidiary
Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

NOTE 1: NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Business

 

Veritas Farms, Inc. (formerly known as SanSal Wellness Holdings, Inc.) (the “Company” or “Veritas FarmsTM”), was incorporated as Armeau Brands Inc. in the State of Nevada on March 15, 2011. On October 13, 2017, the Company filed Amended and Restated Articles of Incorporation with the Nevada Secretary of State changing the name from “Armeau Brands Inc.” to “SanSal Wellness Holdings, Inc.,” and on January 30, 2019, the Company filed a Certificate of Amendment to the Articles of Incorporation with the Nevada Secretary of State changing the name from SanSal Wellness Holdings, Inc. to Veritas Farms, Inc. The Company’s business objectives are to produce natural rich-hemp products, using strict natural protocols and materials yielding broad spectrum phytocannabinoid rich hemp oils, distillates and isolates. The Company is licensed by the Colorado Department of Agriculture to grow industrial hemp on its 135 acre farm pursuant to Federal law.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of March 31, 2021 and March 31, 2020, and the results of operations and cash flows for the periods presented. The results of operations for the three months ending March 31, 2021, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in the Form 10-K for the year ended December 31, 2020, filed with the SEC on April 20, 2021.

 

Principles of Consolidation

 

The accompanying condensed consolidated financial statements reflect the accounts of Veritas Farms, Inc. and the company’s wholly owned subsidiary 271 Lake Davis Holdings, LLC, a Delaware limited liability company (“271 Lake Davis”). All significant inter-company accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from these estimates.

 

Fair Value Measurement

 

The Company has adopted the provisions of Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.

 

The estimated fair value of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. The carrying amounts of the Company’s short and long-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates taken together with other features such as concurrent issuances of warrants and/or embedded conversion options, are comparable to rates of returns for instruments of similar credit risk.

 

5

 

 

Veritas Farms, Inc. and Subsidiary
Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

 

Level 1 – quoted prices in active markets for identical assets or liabilities

 

Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable

 

Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)

 

The Company does not have any assets or liabilities measured at fair value on a recurring basis.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At times, cash and cash equivalents may be in excess of FDIC insurance limits. As of March 31, 2021 and December 31, 2020, the Company had no cash equivalents.

 

Revenue Recognition

 

Under ASC 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the five-step model prescribed under Accounting Standards Update (“ASU”) 2014-09: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.

 

Revenues from product sales are recognized when the customer obtains control of the Company’s product, which occurs at a point in time, typically upon delivery to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have recognized is one year or less or the amount is immaterial.

 

Cost of Goods Sold

 

Hemp Cultivation and Production

 

Cost of goods sold includes the costs directly attributable to production of inventory such as cultivation costs, extraction costs, packaging costs, security, and allocated overhead. Overhead expenses include allocations of rent, administrative salaries, utilities, and related costs.

 

Inventories

 

Inventories consist of growing and processed plants and oils and are valued at the lower of cost or net realizable value. In evaluating whether inventories are stated at lower of cost or net realizable value, management considers such factors as inventories in hand, estimated time to sell such inventories and current market conditions. Write-offs for inventory obsolescence are recorded when, in the opinion of management, the value of specific inventory items has been impaired.

 

6

 

 

Veritas Farms, Inc. and Subsidiary
Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

Property, Plant and Equipment

 

Purchase of property, plant and equipment are recorded at cost. Improvements and replacements of property, plant and equipment are capitalized. Maintenance and repairs that do not improve or extend the lives of property and equipment are charged to expense as incurred. When assets are sold or retired, their cost and related accumulated depreciation are removed from the accounts and any gain or loss is reported in the Consolidated Statements of Operations. Depreciation is provided over the estimated economic useful lives of each class of assets and is computed using the straight-line method.

   

Impairment of Long-Lived Assets

 

The carrying value of long-lived assets are reviewed when facts and circumstances suggest that the assets may be impaired or that the amortization period may need to be changed. The Company considers internal and external factors relating to each asset, including cash flows, local market developments, industry trends and other publicly available information. If these factors and the projected undiscounted cash flows of the Company over the remaining amortization period indicate that the asset will not be recoverable, the carrying value will be adjusted to the fair market value. The Company has determined that no impairment exists at March 31, 2021 and December 31, 2020.

 

Stock-Based Compensation

 

The Company accounts for share-based payments in accordance with ASC Topic 718, “Compensation - Stock Compensation,” which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, “Measurement Objective – Fair Value at Grant Date,” the Company estimates the fair value of the award using the Black-Scholes option pricing model for valuation of the share-based payments. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders.

 

The simplified method is used to determine compensation expense since historical option exercise experience is limited relative to the number of options issued. The compensation cost is recognized ratably using the straight-line method over the expected vesting period.

 

The Company accounts for stock-based compensation to other than employees in the same manner in which it accounts for stock-based compensation for employees.

 

Income Taxes

 

The Company accounts for income taxes under ASC 740, Income Taxes (“ASC 740”). Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.

 

In accordance with ASC Topic 740 management evaluated the Company’s tax positions and concluded that the Company had taken no uncertain tax positions that require adjustment to the financial statements to comply with the provisions of this guidance. The Company is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.

 

7

 

 

Veritas Farms, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

Income tax benefits are recognized for income tax positions taken or expected to be taken in a tax return, only when it is determined that the income tax position will more-likely than-not be sustained upon examination by taxing authorities. The Company has analyzed tax positions taken for filings with the Internal Revenue Service and all tax jurisdictions where it operates. The Company believes that income tax filing positions will be sustained upon examination and does not anticipate any adjustments that would result in a material adverse effect on the Company’s financial condition, results of operations or cash flows. Accordingly, the Company has not recorded any reserves, or related accruals for interest and penalties for uncertain income tax positions at March 31, 2021 and December 31, 2020.

 

Leases

 

The Company has one leased building in Fort Lauderdale, Florida that is classified as operating lease right-of use (“ROU”) assets and operating lease liabilities in the Company’s consolidated balance sheet. ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. Minimum lease payments include only the fixed lease component of the agreement. Operating lease expense is recognized on a straight-line basis over the lease term and is included in cost of Selling, General and Administrative expenses.

 

ASC Topic 842, Leases (“ASC 842”) was effective for us beginning January 1, 2019. The Company elected the available practical expedients on adoption. The adoption had a material impact on our consolidated balance sheets but did not have a material impact on our consolidated income statements. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases. Finance leases are not material to the Company and were not impacted by the adoption of ASC 842, as operating lease liabilities and the corresponding assets were already recorded in the balance sheet under the previous guidance, ASC Topic 840, Leases.

 

Related Party Transactions

 

The Company follows ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions. Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The consolidated financial statements shall include disclosures of related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which statements of operation are presented, and such other information deemed necessary for an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which statements of operations are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

8

 

 

Veritas Farms, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

NOTE 2: GOING CONCERN

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States, which contemplate continuation of the Company as a going concern. However, the Company has sustained substantial losses from operations since its inception. As of and for the period ended March 31, 2021, the Company had an accumulated deficit of $27,821,806, and a net loss of $1,154,659. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. Continuation as a going concern is dependent on the ability to raise additional capital and financing, though there is no assurance of success.

 

In December 2019, a novel strain of coronavirus (COVID-19) emerged. Because COVID-19 infections have been reported throughout the United States, certain federal, state and local governmental authorities have issued stay-at-home orders, proclamations and/or directives aimed at minimizing the spread of COVID-19. The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time, but it may have a material adverse impact on our business, financial condition and results of operations. Management expects that its business will be impacted to some degree, but the significance of the impact of the COVID-19 outbreak on the Company’s business and the duration for which it may have an impact cannot be determined at this time.

 

MANAGEMENT PLANS

 

To become market leaders in the market, the Company will use three primary methods to market its products including: web-based marketing, traditional marketing, and medical marketing.

 

The Company believes that it will require additional financing to fund its growth and achieve profitability The Company anticipates that such financing, will be generated from subsequent public or private offerings of its equity and/or debt securities. Outside financing, in concert with increased profitability of "Big Box" retail orders and Ecommerce allow management to conclude that the Company will continue as a going concern.

 

The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

 

NOTE 3: INVENTORIES

 

Inventory consists of:

 

   March 31,   December 31, 
   2021   2020 
Inventory        
Work In Progress  $4,174,062   $4,202,811 
Finished Goods   1,154,403    1,232,944 
Other   459,873    456,228 
Inventory  $5,788,338   $5,891,983 

 

NOTE 4: PROPERTY AND EQUIPMENT

 

   Estimated   March 31,   December 31, 
   Life   2021   2020 
PROPERTY AND EQUIPMENT               
Land and Land Improvements   -   $398,126   $398,126 
Building and Improvements   39    1,553,722    1,553,722 
Greenhouse   39    965,388    965,388 
Fencing and Irrigation   15    203,793    203,793 
Machinery and Equipment   7    2,480,474    2,480,474 
Furniture and Fixtures   7    236,344    236,344 
Computer Equipment   5    20,053    20,053 
Vehicles   5    120,206    120,206 
        $5,978,106   $5,978,106 
Less Accumulated Depreciation        (1,612,153)   (1,483,736)
Property and Equipment       $4,365,953   $4,494,370 

 

Total depreciation expense was $128,942 and $101,174 for the three month periods ending March 31, 2021 and March 31, 2020, respectively.

 

9

 

 

Veritas Farms, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

NOTE 5: LONG-TERM DEBT

 

Long-term debt consisted of the following:

 

   March 31,   December 31, 
   2021   2020 
         
Notes Payable which require monthly payments of $3,058, $555, and $1,415, including interest at 5.16% per annum until December 1, 2022, May 1, 2023, and August 1, 2024, when the balances are due in full. The notes are secured by specific assets of the Company.  $135,777   $118,627 
           
Note Payable which requires monthly payments of $639, including interest at 3.4% per annum until April 1, 2025, when the balance is due in full. The note is secured by specific assets of the Company.   31,930    66,080 
           
In May 2020, the Company received a loan in the amount of $803,994 under the Payroll Protection Program (“PPP Loan”). The loan accrues interest at a rate of 1% and has an original maturity date of two years which can be extended to five years by mutual agreement of the Company and SBA. (A)   803,994    803,994 
           
In September 2020, the Company received a loan in the amount of $159,900 from the Small Business Administration as an Economic Injury Disaster Loan (“EIDL”). The loan accrues interest at the rate of 3.75% and has an original maturity date of 30 years. (B)   159,900    159,900 
           
In February 2021, the Company received a loan in the amount of $803,994 under the Payroll Protection Program (“PPP Loan”).  The loan accrues interest at a rate of 1% and has an original maturity date of five years. (C)   803,994    - 
    1,935,595    1,148,601 
Less Current Portion   (1,675,984)   (870,074)
Long-Term Debt - net of current portion  $259,611   $278,527 

 

Future principal payments for the next 5 years are as follows for the years ended December 31:

 

   March 31,
2021
 
2021  $25,499 
2022   67,996 
2023   874,747 
2024   836,807 
2025   24,494 
Thereafter   106,052 
   $1,935,595 

 

(A) In May 2020, the Company received a loan in the amount of $803,994 under the Payroll Protection Program (“PPP Loan”). The loan accrues interest at a rate of 1% and has an original maturity date of two years which can be extended to five years by mutual agreement of the Company and SBA. The PPP loan contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties.

 

Under the terms of the loan, a portion or all of the loan is forgivable to the extent the loan proceeds are used to fund qualifying payroll, rent and utilities during a designated twenty-four week period. Payments are deferred until the SBA determines the amount to be forgiven. The Company utilized the proceeds of the PPP loan in a manner which should enable qualification as a forgivable loan. However, no assurance can be provided that all or any portion of the PPP loan will be forgiven. The balance on this PPP loan was $803,994 as of March 31, 2021 and has been classified as a short-term liability in notes payable.

 

(B) In September 2020, the Company received a loan in the amount of $159,900 from the Small Business Administration as an Economic Injury Disaster Loan (“EIDL”). The loan accrues interest at the rate of 3.75% and has an original maturity date of 30 years.

 

Up to $10,000 of the EIDL can be forgiven as long as such funds were utilized to provide working capital. The residual amount of the loan is payable under the above terms. The first payment due is deferred two years. The entirety of the loan as of March 31, 2021 has been classified as a long-term liability in notes payable. 

 

10

 

 

Veritas Farms, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

(C) In February 2021, the Company received a loan in the amount of $803,994 under the Payroll Protection Program (“PPP Loan”). The loan accrues interest at a rate of 1% and has an original maturity date of five years. The PPP loan contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties.

 

Under the terms of the loan, a portion or all of the loan is forgivable to the extent the loan proceeds are used to fund qualifying payroll, rent and utilities during a designated twenty-four week period. Payments are deferred until the SBA determines the amount to be forgiven. The Company intends to utilize the proceeds of the PPP loan in a manner which should enable qualification as a forgivable loan. However, no assurance can be provided that all or any portion of the PPP loan will be forgiven. The balance on this PPP loan was $803,994 as of March 31, 2021 and has been classified as a short-term liability in notes payable.

 

NOTE 6: CONVERTIBLE DEBT

 

In March 2020, the Company secured a $200,000 loan from a single investor, evidenced by a one-year convertible promissory note (the “Convertible Note”). The Convertible Note bears interest at the rate of ten percent (10%) per annum, which accrues and is payable together with principal at maturity. The note matures on the first anniversary of the original issuance date or such earlier date on which this Note becomes due in accordance with its terms.

 

Principal and accrued interest under the Convertible Note may, at the option of the holder, be converted in its entirety into shares of our common stock at a conversion price of $0.40 per share, subject to adjustment for stock splits, stock dividends and similar recapitalization transactions. The Company determined that there was a beneficial conversion feature of $95,000 relating to this note which is being amortized over the life of the note, using the using the effective interest method. The note is presented net of a discount of $0 as of March 31, 2021 and $23,750 as of December 31, 2020 on the accompanying balance sheet with amortization to interest expense of $23,750 for the period ended March 31, 2021. As of March 31, 2021, $21,556 of interest has been accrued. As of March 31, 2021, the Company is in default on the Convertible Note which was due on March 6, 2021. See Note 12: Subsequent Events,

 

NOTE 7: STOCK-BASED COMPENSATION

 

The Company approved its 2017 Stock Incentive Plan on September 27, 2017 (the “Incentive Plan”) which authorizes the Company to grant or issue non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units and other equity awards up to a total of 6,927,747 shares. Under the terms of the Incentive Plan, awards may be granted to our employees, directors or consultants. Awards issued under the Incentive Plan vest as determined at the time of grant by the Board of Directors or any of the Committees appointed under the Incentive Plan.

 

The Company’s outstanding stock options typically have a 10-year term. Outstanding non-qualified stock options granted to employees and consultants vest on a case by case basis. Outstanding incentive stock options issued to employees typically vest over a three-year period. The incentive stock options granted vest based solely upon continued employment (“time-based”). The Company’s time-based share awards that vest in their entirety at the end of three-year periods, time-based share awards where 33.3% of the award vests on each of the three anniversary dates. Outstanding incentive stock options issued to executives typically vest partially upon grant date, with the residual vesting over the subsequent 6 or 12 months.

 

Stock based compensation expense was as follows in the three month periods ended March 31, 2021 and March 31, 2020:

 

   Three months Ended
March 31:
 
   2021   2020 
Total Stock-based Compensation Expense  $53,412   $472,726 
           

 

11

 

 

Veritas Farms, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

Stock option activity was as follows in the period ended March 31, 2021:

 

   Stock
Options
   Weighted-Average
Exercise
   Weighted-Average
Remaining
 
Outstanding at December 31, 2020   4,193,751                         
Granted   -    -    - 
Exercised   -    -    - 
Forfeited/Cancelled   (18,750)  $1.51    - 
Outstanding at March 31, 2021   4,175,001   $1.14    8.16 
                
Vested at March 31, 2021   3,903,343   $1.14    7.99 
Exercisable at March 31, 2021   3,903,343   $1.14    7.99 

 

Valuation Assumptions    
Risk-free interest rate   0.36% – 1.79 % 
Expected dividend yield   0%
Expected stock price volatility   213% to 227 % 
Expected life of stock options (in years)   10 

 

Stock option activity was as follows in the period ended March 31, 2020:

 

   Stock
Options
   Weighted-Average
Exercise
   Weighted-Average
Remaining
 
Outstanding at December 31, 2019   4,318,750   $1.14    8.91 
Granted   -   $-    - 
Exercised   -    -    - 
Forfeited/Cancelled   -   $-    - 
Outstanding at March 31, 2020   4,318,750    1.14    8.66 
                
Vested at March 31, 2020   3,154,407   $1.14    8.48 
Exercisable at March 31, 2020   3,154,407   $1.14    8.48 

 

Valuation Assumptions    
Risk-free interest rate   2.14% – 2.94 % 
Expected dividend yield   0%
Expected stock price volatility   105% to 108 % 
Expected life of stock options (in years)   10 

 

NOTE 8: LEASES

 

The Company recognized the following related to leases in its Balance Sheet:

 

   March 31,   December 31, 
   2021   2020 
   unaudited     
Right of Use Lease Liabilities        
Current Portion  $86,253   $240,324 
Long-term Portion   97,737    730,164 
   $183,990   $970,488 

 

On June 22, 2018, the Company entered into a sublease agreement with EDSA Inc. for the lease of the Company’s principal executive offices in Fort Lauderdale, Florida. The lease went into effect as of July 1, 2018 with a term of three years expiring August 31, 2021. The lease contains annual escalators and charges Florida sales tax. Total amortization expense related to the lease was $20,152 and $20,152 for the three month period ending March 31, 2021 and March 31, 2020, respectively.

 

12

 

 

Veritas Farms, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

On December 2, 2019, the Company entered into a 61 month lease with Majestic Commercenter Phase 9, LLC. (Majestic”), for warehousing, distribution and related administration office in Aurora, Colorado. The lease allows for an abated first month of rent. The lease contains annual escalators in addition to other periodic payments pertaining to taxes, utilities, insurance and common area costs. Total amortization expense related to the lease was $0 and $9,286 for the three month periods ending March 31, 2021 and March 31, 2020, respectively.

 

On February 10, 2021, the Company entered into a conditional lease termination agreement with Majestic pursuant to which the Company terminated the lease with Majestic (“Termination Agreement”). Pursuant to the terms of the Termination Agreement, Veritas Farms made one payment of $125,000 on February 23, 2021. The final amount of $125,000 was paid to Majestic by April 30, 2021, upon which both parties were released from all further obligations to each other. The net expense on the termination of the lease was $244,840. The extra-ordinatry expense was reported as Other Expenses, Loss on Lease Termination - Aurora.

 

On February 11, 2021, the Company entered into a 3 year lease with Cheyenne Avenue Holdings, LLC for warehouse and distribution facilities. The lease contains annual escalators. The Company analyzed the classification of the lease under ASC 842, and as it did not meet any of the criteria for a financing lease it has been classified as an operating lease. The Company determined the Right of Use asset and Lease liability values at inception calculated at the present value of all future lease payments for the lease term, using an incremental borrowing rate of 5%. The Right of Use Asset value was $160,476 and the Liability was $160,476. The Lease Liability will be expensed each month, on a straight-line basis, over the life of the lease. Total amortization expense related to the lease was $4,711 and $0 for the three month periods ending March 31, 2021 and March 31, 2020 respectively.

 

As of March 31, 2021, and December 31, 2020, operating leases have no minimum rental commitments.

 

NOTE 9: COMMON STOCK

 

In September 2019, the Company commenced a $4.0 million private offering of up to 8,000,000 Units (which may be increased by the Company up to 12,000,000 Units) at a price of $0.50 per Unit. Each Unit consists of (a) two shares of common stock; and (b) one warrant, entitling the holder to purchase one share of our common stock at an exercise price of $0.50 at any time through August 31, 2025. As of December 31, 2020, the Company sold 2,080,000 Units in the private offering for gross proceeds of $1,040,000 with offering costs of $154,965 resulting in net proceeds of $885,035. As of March 31, 2021, the Company sold an additional 200,000 Units for gross proceeds of $100,000 with offering costs of $13,105 resulting in net proceeds of $86,895. The Company also entered into a registration rights agreement with the investors which states, among other things, that the Company shall use commercially reasonable efforts to prepare and file with the SEC a registration statement covering, among other things, the resale of all or such portion of the registrable securities that are not then registered on an effective registration statement.

 

In March of 2020, the Company issued 153,279 shares of common stock in accordance with a cashless exercise of warrants.

 

NOTE 10: CONCENTRATIONS

 

The Company had no single customer in the three months ended March 31, 2021 that accounted for more than 10% of sales. For the three months ended March 31, 2020, one customer accounted for 14% of sales.

 

The Company had two customers at March 31, 2021 accounting for 47% and 23% of accounts receivable. At December 31, 2020, the Company had two customers accounting for 43% and 17% of accounts receivable.

 

NOTE 11: RELATED PARTY

 

A law firm owned by the brother of Alexander M. Salgado, our Chief Executive Officer, rendered legal services to the Company. The firm incurred expenses in aggregate of $13,825 and $57,500 for such services during the three month periods ended March 31, 2021 and March 31, 2020, respectively.

 

The Company issued stock incentives to various directors and employees.

 

NOTE 12: SUBSEQUENT EVENTS

 

On May 11, 2021 (the “Effective Date”), the Company entered into a Securities Purchase Agreement (the “SPA”) with The Cornelis F. Wit Revocable Living Trust, of which Cornelis F. Wit is trustee (the “Purchaser”), an existing shareholder, pursuant to which the Company contemporaneously sold to the Purchaser an aggregate of (a) 2,000,000 shares of its Series A Convertible Preferred Stock (the “Series A Preferred Shares”); and (b) 1,000,000 shares of its Series B Convertible Preferred Stock (the “Series B Preferred Shares,” and together with the Series A Preferred Shares, collectively, the “Preferred Shares”) in exchange for (i) the payment of $2,000,000 (including $302,500 principal plus accrued but unpaid interest in bridge financing provided by the Purchaser to the Company during April 2021); and (ii) the surrender by the purchaser to the Company of 2,000,000 units (the “Units”), each Unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock in accordance with the terms of the subscription agreements for the purchase of the Units entered into by the Purchaser and the Company in September and October 2020. As a result of the transaction and the voting rights accorded the Preferred Shares as set forth below, the Purchaser now holds approximately 88% of the voting power of the Company and accordingly, a “Change in Control” has occurred.

 

13

 

 

Veritas Farms, Inc. and Subsidiary

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

The Series A Preferred Shares have a stated value of $1.00 per share. Each Series A Preferred Share is convertible into Common Stock at the option of the holder thereof at a conversion rate of $0.05 per share of Common Stock. The conversion rate is subject to adjustment in the event of stock splits, stock dividends, other recapitalizations and similar events, as well as in the event of issuance by the Company of shares of Common Stock or securities exercisable for, convertible into or exchangeable for Common Stock at an effective price per share less than the conversion rate then in effect (other than certain customary exceptions). In respect of rights to the payment of dividends and the distribution of assets in the event of any liquidation, dissolution or winding-up of the Company, the Series A Preferred Shares rank (a) junior to the Company’s Series B Shares; and (b) senior to (i) the Company’s common stock, par value $0.001 per share (the “Common Stock”) and any other class or series of stock (including other series of Preferred Stock) of the Company (collectively, “Junior Stock”). From and after the date of the issuance of Series A Preferred Shares, dividends at the rate per annum of 8%, compounded annually, accrue daily on the Stated Value (the “Accruing Dividends). Accruing Dividends shall accrue from day to day, whether or not declared, and shall be cumulative; provided, however, such Accruing Dividends shall be payable only when, as, and if declared by the Board of Directors and the Company shall be under no obligation to pay such Accruing Dividends except as set forth herein. The Company shall not declare, pay or set aside any dividends on shares of any other class or series of capital stock of the Company (other than dividends on (a) shares of Series B Preferred Shares; and (b) Common Stock payable in shares of Common Stock) unless (in addition to the obtaining of any consents required elsewhere in the Articles of Incorporation) the holders of the Series A Preferred Shares then outstanding shall first receive, or simultaneously receive, a dividend on each outstanding share of Series A Preferred Share in an amount at least equal to the sum of (a) the amount of the aggregate Accruing Dividends then accrued on such Series A Preferred Shares and not previously paid; and (b) (i) in the case of a dividend on Common Stock or any class or series that is convertible into Common Stock, that dividend per Series A Preferred Share as would equal the product of (A) the dividend payable on each share of such class or series determined, if applicable, as if all shares of such class or series had been converted into Common Stock; and (B) the number of shares of Common Stock issuable upon conversion of a Series A Preferred Share, in each case calculated on the record date for determination of holders entitled to receive such dividend; or (ii) in the case of a dividend on any class or series that is not convertible into Common Stock, at a rate per Series A Preferred Share determined by (A) dividing the amount of the dividend payable on each share of such class or series of capital stock by the original issuance price of such class or series of capital stock (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to such class or series); and (B) multiplying such fraction by an amount equal to the Stated Value of the Series A Preferred Shares; provided, that if the Company declares, pays or sets aside, on the same date, a dividend on shares of more than one class or series of capital stock of the Company, the dividend payable to the holders of Series A Preferred Shares shall be calculated based upon the dividend on the class or series of capital stock that would result in the highest Series A Preferred Share.

 

The Series B Preferred Shares have a stated value of $1.00 per share. Each Series A Preferred Share is convertible into Common Stock at the option of the holder thereof at a conversion rate of $0.20 per share of Common Stock. The conversion rate is subject to adjustment in the event of stock splits, stock dividends, other recapitalizations and similar events, as well as in the event of issuance by the Company of shares of Common Stock or securities exercisable for, convertible into or exchangeable for Common Stock at an effective price per share less than the conversion rate then in effect (other than certain customary exceptions). In respect of rights to the payment of dividends and the distribution of assets in the event of any liquidation, dissolution or winding-up of the Company, the Series B Preferred Shares rank senior to the (a) Series A Preferred Shares; (b) the Company’s Common Stock and any other class or series of Junior Stock. From and after the date of the issuance of Series B Preferred Shares, dividends at the rate per annum of 8%, compounded annually, accrue daily on the Stated Value (the “Accruing Dividends). Accruing Dividends shall accrue from day to day, whether or not declared, and shall be cumulative; provided, however, such Accruing Dividends shall be payable only when, as, and if declared by the Board of Directors and the Company shall be under no obligation to pay such Accruing Dividends except as set forth herein. The Company shall not declare, pay or set aside any dividends on shares of any other class or series of capital stock of the Company (other than dividends on (a) shares of Series B Preferred Shares; and (b) Common Stock payable in shares of Common Stock) unless (in addition to the obtaining of any consents required elsewhere in the Articles of Incorporation) the holders of the Series B Preferred Shares then outstanding shall first receive, or simultaneously receive, a dividend on each outstanding share of Series B Preferred Share in an amount at least equal to the sum of (a) the amount of the aggregate Accruing Dividends then accrued on such Series B Preferred Shares and not previously paid; and (b) (i) in the case of a dividend on Common Stock or any class or series that is convertible into Common Stock, that dividend per Series B Preferred Share as would equal the product of (A) the dividend payable on each share of such class or series determined, if applicable, as if all shares of such class or series had been converted into Common Stock; and (B) the number of shares of Common Stock issuable upon conversion of a Series B Preferred Share, in each case calculated on the record date for determination of holders entitled to receive such dividend; or (ii) in the case of a dividend on any class or series that is not convertible into Common Stock, at a rate per Series B Preferred Share determined by (A) dividing the amount of the dividend payable on each share of such class or series of capital stock by the original issuance price of such class or series of capital stock (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to such class or series); and (B) multiplying such fraction by an amount equal to the Stated Value of the Series B Preferred Shares; provided, that if the Company declares, pays or sets aside, on the same date, a dividend on shares of more than one class or series of capital stock of the Company, the dividend payable to the holders of Series B Preferred Shares shall be calculated based upon the dividend on the class or series of capital stock that would result in the highest Series B Preferred Share.

 

Pursuant to the SPA, the Purchaser and the Company agreed to fix the number of members of the board of directors of the Company at five (5), three of whom shall be designated by the Purchaser and two of whom shall be “independent” and acceptable to the Purchaser. In addition, the Purchaser has been accorded certain registration rights under the Securities Act of 1933, as amended, with respect to the shares of Common Stock issuable upon conversion of the Preferred Shares and ongoing financial and other information rights with respect to the Company.

 

On May 14, 2021, the single investor signed a six-month extension to the $200,000 Convertible Note. The note will become due in September 2021.

 

14

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Unless the context otherwise requires, references in this report to “the Company,” “Veritas Farms,” “we,” “us” and “our” refer to Veritas Farms, Inc. and its subsidiary.

 

All share and per share information in this report has been adjusted to give effect to a one-for-four reverse stock split implemented by the Company on September 19, 2019.

 

Forward-Looking Statements

 

Certain statements made in this report are “forward-looking statements” regarding the plans and objectives of management for future operations. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based, in part, on assumptions involving judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Although we believe that our assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein particularly in view of the current state of our operations, the inclusion of such information should not be regarded as a statement by us or any other person that our objectives and plans will be achieved. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

 

Business Overview

 

Veritas Farms is a vertically-integrated agribusiness focused on growing, producing, marketing, and distributing superior quality, whole plant, full spectrum hemp oils and extracts containing naturally occurring phytocannabinoids. Veritas Farms owns and operates a 140-acre farm in Pueblo, Colorado, capable of producing over 200,000 proprietary full spectrum hemp plants containing naturally occurring phytocannabinoids which can potentially yield a minimum annual harvest of over 200,000 pounds of outdoor-grown industrial hemp. While part of the cannabis family, hemp, which contains less than 0.3% tetrahydrocannabinol (“THC”), the psychoactive compound that produces the “high” in marijuana, is distinguished from marijuana by its use, physical appearance and lower THC concentration (marijuana generally has a THC level of 10% or more). The Company also operates approximately 15,000 sq. ft. of climate-controlled greenhouses to produce a consistent supply of year-round indoor-cultivated hemp. In addition, there is a 10,000 sq. ft. onsite facility used for processing raw hemp, oil extraction, formulation laboratories, and quality/purity testing. Veritas Farms is registered with the Colorado Department of Agriculture to grow industrial hemp and with the Colorado Department of Public Health and Environment to process hemp and manufacture hemp products in accordance with Colorado’s hemp program.

 

Veritas Farms meticulously processes its hemp crop to produce superior quality whole-plant hemp oil, extracts and derivatives which contain the entire broad spectrum of cannabinoids extracted from the flowers and leaves of hemp plants. Whole-plant hemp oil is known to provide the essential phytocannabinoid “entourage effect” resulting from the synergistic absorption of the entire broad spectrum of unique hemp cannabinoids by the receptors of the human endocannabinoid system. As a result, Veritas Farms believes that its products are premier quality cannabinoids and are highly sought after by consumers and manufacturers of premium hemp products.

 

Veritas Farms has developed a wide variety of formulated phytocannabinoid-rich hemp products containing naturally occurring phytocannabinoids which are marketed and distributed by the Company under its Veritas Farms brand name. Our products are also available in bulk, white label and private label custom formulations for distributors and retailers. These types of products are in high demand by health food markets, wellness centers, physicians and other healthcare practitioners.

 

15

 

 

Veritas Farms products (70+ SKUs) include vegan capsules, gummies, tinctures, lotions, salves, cream and oral syringes. All product applications come in various flavors and strength formulations, in addition to bulk volume sales. Many of the Company’s whole-plant hemp oil products and formulations are available for purchase online directly from the Company through its Veritas Farms website, www.theVeritasFarms.com, as well as through numerous other online retailers and “brick and mortar” retail outlets.

 

The branding of the Company’s line of hemp oil and extract product has enabled market penetration during 2020 and 2021 into large retail chains vastly increasing brand exposure and awareness. The initial rollouts have been successful in creating distribution opportunities into thousands of new retail outlets across the country (over 8,000 retail outlets as of the date of this report). The shift from smaller order fulfilment to larger “big box store” orders creates an economy of scale and also offers the opportunity for the Company to achieve increased profitability.

 

As of the date of this report the Company has secured distribution into the following chain stores:

 

CVS Rite Aid Kinney Drugs Niemann Supermarkets
Bashas Giant Eagle Tops Harris Teeter
Bi Mart Smiths Fred Meyer QFC
King Soopers Winn Dixie Bi-Lo Mariano’s
Fruth Weis Bartel Drugs Bed Bath & Beyond
Kroger Save Mart Publix Southern Wine

 

Recent Developments

 

Securities Purchase Agreement

 

On May 11, 2021 (the “Effective Date”), the Company entered into a Securities Purchase Agreement (the “SPA”) with The Cornelis F. Wit Revocable Living Trust, of which Cornelis F. Wit is trustee (the “Purchaser”), an existing shareholder, pursuant to which the Company contemporaneously sold to the Purchaser an aggregate of (a) 2,000,000 shares of its Series A Convertible Preferred Stock (the “Series A Preferred Shares”); and (b) 1,000,000 shares of its Series B Convertible Preferred Stock (the “Series B Preferred Shares,” and together with the Series A Preferred Shares, collectively, the “Preferred Shares”) in exchange for (i) the payment of $2,000,000 (including $302,500 principal plus accrued but unpaid interest in bridge financing provided by the Purchaser to the Company during April 2021); and (ii) the surrender of 2,000,000 units (the “Units”), each Unit consisting of two shares of common stock and one warrant to purchase an additional share of common stock in accordance with the terms of the subscription agreements for the purchase of the Units entered into by the Purchaser and the Company in September and October 2020. As a result of the transaction and the voting rights accorded the Preferred Shares as set forth below, the Purchaser now holds approximately 88% of the voting power of the Company and accordingly, a “Change in Control” has occurred.

 

Pursuant to the SPA, the Purchaser and the Company agreed to fix the number of members of the board of directors of the Company at five (5), three of whom shall be designated by the Purchaser and two of whom shall be “independent” and acceptable to the Purchaser. In addition, the Purchaser has been accorded certain registration rights under the Securities Act of 1933, as amended, with respect to the shares of Common Stock issuable upon conversion of the Preferred Shares and ongoing financial and other information rights with respect to the Company.

 

Management Changes

 

In connection with the consummation of the issuance and sale of the Preferred Shares to the Purchaser pursuant to the SPA, on the Effective Date, Alexander M. Salgado stepped down as the Company’s Chief Executive Officer and a director and Dr. Bao T. Doan and Marc J. Horowitz resigned as directors of the Company. In addition, Michael Pelletier stepped down as an employee of the Company, but agreed to continue to serve as the Company’s Chief Financial Officer for an interim period in order to transition to his successor.

 

16

 

 

Contemporaneously therewith, Stephen E. Johnson, Kuno D. van der Post and Craig J. Fabel were elected and appointed as the Purchaser’s designees on the board of directors. In addition, Mr. Johnson was appointed as Chief Executive Officer and President of the Company, and Ramon Pino, was appointed as Executive Vice President of Finance, Treasurer and Secretary of the Company.

 

Corporate Information

 

The Company was incorporated in the state of Nevada on March 15, 2011 under the name Armeau Brands Inc. and changed its name to SanSal Wellness Holdings, Inc. on October 13, 2017. On January 30, 2019, the Company changed its name from SanSal Wellness Holdings, Inc. to Veritas Farms, Inc.

 

Our executive offices are located at 1512 E. Broward Boulevard, Suite 300, Fort Lauderdale, FL 33301 and our telephone number is (833)691-4367. Our corporate websites are www.theveritasfarms.com and www.sansalwellness.com. Information appearing on our websites is not part of this Quarterly Report on Form 10-Q.

 

Results of Operations

 

Three months ended March 31, 2021 compared to three months ended March 31, 2020

 

Revenues. We had net sales for the three months ended March 31, 2021 of $888,261, as compared to $1,154,311 for the three months ended March 31, 2020. The COVID-19 outbreak had an adverse effect on “brick and mortar” sales of our products and the timing of orders from a number of our retail customers. Sales include bulk oils for wholesale, vegan capsules, tinctures, lotions, salves and oral syringes, all in various potency levels and flavors. In addition to the more established CBD channels, the Company expanded its product lines to include beauty products, pet chews, pet health and sports through strategic partnerships with contract manufacturers.

  

Cost of Sales. All expenses incurred to grow, process, and package the finished goods are included in our cost of sales. Cost of sales for the three months ended March 31, 2021 decreased to $601,428 from $676,698 for the three months ended March 31, 2020. The Company has transitioned from smaller orders to more “Big Box” retail and e-commerce orders.

 

Gross Profit. We had gross profit of $286,833 for the three months ended March 31, 2021, as compared to gross profit of $477,613 for the three months ended March 31, 2020. The decrease in gross profit can be directly related to the decrease in sales during the three months ended March 31, 2021 as compared to the three months ended March 31, 2020.

 

Selling, General and Administrative Expenses. Selling, general and administrative expenses decreased to $1,411,786 for the three months ended March 31, 2021, from $2,795,818 for the three months ended March 31, 2020. This reduction reflects expense reductions, including a reduction in personnel and 20% pay cuts taken by management and other senior staff in response to the COVID-19 outbreak. General and administrative expenses consist primarily of administrative personnel costs, facilities expenses, professional fee expenses and marketing costs for our Veritas Farms brand products.

 

Interest Expense. Interest expense for the three months ended March 31, 2021 was $29,706, as compared to $7,064 for the three months ended March 31, 2020, $5,420 of which was attributable to a loan from a principal shareholder. Interest expense increased in the 2021 quarter from the 2020 quarter due to the interest method amortization of a beneficial conversion feature.

 

Net Loss. As a result of all the foregoing, net loss for the three months ended March 31, 2021, decreased to ($1,154,659) or ($0.03) per share based on 45,836,802 weighted average shares outstanding, from ($2,325,269) or ($0.06) per share for the three months ended March 31, 2020, based on 41,549,431 weighted average shares outstanding.

 

17

 

 

Liquidity and Capital Resources

 

As of March 31, 2021, total assets were $11,368,344, as compared to $12,408,021 at December 31, 2020. The decrease in assets is primarily due to a decrease in Property Plant and Equipment net of accumulated amortization and decreased deposits.

  

Total current liabilities as of March 31, 2021 were $4,377,981, as compared to $3,751,963 at December 31, 2020. The increase was mainly due to the Company receiving a second PPP loan of $803,994.

 

Net cash used in operating activities was $913,352 for the three months ended March 31, 2021, as compared to $1,046,222 for the three months ended March 31, 2020. The decrease is largely attributable to the reduction of net losses and reductions in prepaid expenses, accounts payable and stock based compensation.

 

Net cash used in investing activities was $0 for the three months ended March 31, 2021 as compared to net cash used of $77,423 for the three months ended March 31, 2020, reflecting reduced capital expenditures in 2021.

 

Net cash provided by financing activities was $897,640 for the three months ended March 31, 2021 as compared to $184,645 for the three months ended March 31, 2020. The 2021 number reflects the net proceeds of $803,994 from the PPP loan received in March, net proceeds of $86,895 from initial closings under a private placement, while the 2020 amount reflects the net proceeds from of a $200,000 convertible loan received in March 2020.

 

Our primary sources of capital to develop and implement our business plan and expand our operations have been the proceeds from private offerings of our equity securities, capital contributions made by members prior to completion of the September 2017 acquisition of 271 Lake Davis Holdings, LLC by the Company and loans from shareholders.

 

In September 2019, the Company commenced a $4.0 million private offering of up to 8,000,000 Units (which may be increased by the Company up to 12,000,000 Units) at a price of $0.50 per Unit. Each Unit consists of (a) two shares of common stock; and (b) one warrant, entitling the holder to purchase one share of our common stock at an exercise price of $0.50 at any time through August 31, 2025. As of December 31, 2020, the Company sold 2,080,000 Units in the private offering for gross proceeds of $1,040,000 with offering costs of $154,965 resulting in net proceeds of $885,035. As of March 31, 2021, the Company sold an additional 200,000 Units for gross proceeds of $100,000 with offering costs of $13,105 resulting in net proceeds of $86,895. The Company also entered into a registration rights agreement with the Investors which states, among other things, that the Company shall use commercially reasonable efforts to prepare and file with the SEC a registration statement covering, among other things, the resale of all or such portion of the registrable securities that are not then registered on an effective registration statement.

 

In March 2020, the Company secured a $200,000 loan from a single investor, evidenced by a one-year convertible promissory note (the “Convertible Note”). The Convertible Note bears interest at the rate of ten percent (10%) per annum, which accrues and is payable together with principal at maturity. Principal and accrued interest under the Convertible Note may, at the option of the holder, be converted in its entirety into shares of our common stock at a conversion price of $0.40 per share, subject to adjustment for stock splits, stock dividends and similar recapitalization transactions. As of March 31, 2021, the Company is in default on the note which was due on March 6, 2021. See Note 12: Subsequent Events.

 

On May 11. 2021, the Company consummated the issuance and sale of the Preferred Shares to the Purchaser described under “Recent Developments” above, which generated gross proceeds of $2,000,000 (including certain bridge financing previously furnished by the Purchaser to the Company in April 2021).

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States, which contemplate continuation of the Company as a going concern. However, the Company has sustained substantial losses from operations since its inception. As of and for the period ended March 31, 2021, the Company had an accumulated deficit of ($27,821,806) and a net loss of ($1,154,659). These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. Continuation as a going concern is dependent on the ability to raise additional capital and financing, though there is no assurance of success.

 

The Company believes that it will require additional financing to fund its growth and achieve profitability The Company anticipates that such financing, will be generated from subsequent public or private offerings of its equity and/or debt securities. While we believe additional financing will be available to us as needed, there can be no assurance that equity financing will be available on commercially reasonable terms or otherwise, when needed. Moreover, any such additional financing may dilute the interests of existing shareholders. The absence of additional financing, when needed, could substantially harm the Company, its business, results of operations and financial condition.

 

18

 

 

Effects of the Current Coronavirus (COVID-19) Pandemic on the Company

 

The adverse public health developments and economic effects of the current COVID-19 pandemic in the United States, could adversely affect the Company’s customers and suppliers as a result of quarantines, facility closures, closing of “brick and mortar” retail outlets and logistics restrictions imposed or which otherwise occur in connection with the pandemic. More broadly, the high degree unemployment resulting from the pandemic could potentially lead to an extended economic downturn, which would likely decrease spending, adversely affect demand for our products and services and harm our business, results of operations and financial condition. At this time, we cannot accurately predict the effect the COVID-19 pandemic will have on the Company.

 

Critical Accounting Policies

 

Revenue Recognition

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry specific guidance. This new standard requires a company to recognize revenues when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. The FASB subsequently issued the following amendments to ASU 2014-09 that have the same effective date and transition date: ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations; ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing; ASU 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients; and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers. The Company adopted these amendments with ASU 2014-09 (collectively, the new revenue standards).

 

The new revenue standards became effective for the Company on January 1, 2019 and were adopted using the modified retrospective method. The adoption of the new revenue standards as of January 1, 2019 did not change the Company’s revenue recognition as the majority of its revenues continue to be recognized when the customer takes control of its product. As the Company did not identify any accounting changes that impacted the amount of reported revenues with respect to its product revenues, no adjustment to retained earnings was required upon adoption.

 

Under the new revenue standards, the Company recognizes revenues when its customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the five-step model prescribed under ASU 2014-09: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.

 

Revenues from product sales are recognized when the customer obtains control of the Company’s product, which occurs at a point in time, typically upon delivery to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have recognized is one year or less or the amount is immaterial.

 

Property, Plant and Equipment

 

Purchase of property, plant and equipment are recorded at cost. Improvements and replacements of property, plant and equipment are capitalized. Maintenance and repairs that do not improve or extend the lives of property and equipment are charged to expense as incurred. When assets are sold or retired, their cost and related accumulated depreciation are removed from the accounts and any gain or loss is reported in the Statements of Operations. Depreciation is provided over the estimated economic useful lives of each class of assets and is computed using the straight-line method.

 

Impairment of Long-Lived Assets

 

The carrying value of long-lived assets are reviewed when facts and circumstances suggest that the assets may be impaired or that the amortization period may need to be changed. The Company considers internal and external factors relating to each asset, including cash flows, local market developments, industry trends and other publicly available information. If these factors and the projected undiscounted cash flows of the Company over the remaining amortization period indicate that the asset will not be recoverable, the carrying value will be adjusted to the fair market value.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates included deferred revenue, costs incurred related to deferred revenue, the useful lives of property and equipment and the useful lives of intangible assets.

 

19

 

 

Off-Balance Sheet Arrangements

 

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risks.

 

As a “smaller reporting company,” we are not required to provide the information required by this Item.

 

Item 4. Controls and Procedures.

 

Management’s Report on Disclosure Controls and Procedures

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Internal control over financial reporting is a process designed by, or under the supervision of, our Chief Executive Officer (our Principal Executive Officer) and our Chief Financial Officer (our Principal Financial and Accounting Officer), to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”). Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with GAAP, and that receipts and expenditures of our company are being made only in accordance with authorizations of management and directors of our Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our Company’s assets that could have a material effect on the consolidated financial statements. Because of its inherent limitations, internal control over financial reporting may not provide absolute assurance that a misstatement of our consolidated financial statements would be prevented or detected.

 

Further, the evaluation of the effectiveness of internal control over financial reporting was made as of a specific date, and continued effectiveness in future periods is subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our Chief Executive Officer (our Principal Executive Officer) and our Chief Financial Officer (our Principal Financial and Accounting Officer) conducted an evaluation of the effectiveness of our internal control over financial reporting as of March 31, 2021 in accordance with the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control — Integrated Framework. Based on this assessment, our Chief Executive Officer (our Principal Executive Officer) and our Chief Financial Officer (our Principal Financial and Accounting Officer) identified the following two material weaknesses that have caused management to conclude that, as of March 31, 2021, our disclosure controls and procedures, and our internal control over financial reporting, were not effective at the reasonable assurance level in that:

 

(a) We do not have written documentation of our internal control policies and procedures. Our Chief Executive Officer and our Chief Financial Officer evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

 

(b) We do not have sufficient segregation of duties within accounting functions, which is a basic internal control. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Documentation of our controls and the continued changes to assure segregation of duties are being performed. Our Chief Executive Officer and our Chief Financial Officer evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

 

To address these material weaknesses, our Chief Executive Officer and our Chief Financial Officer performed additional analyses and other procedures to ensure that the consolidated financial statements included herein fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented. Accordingly, we believe that the consolidated financial statements included in this report fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented. We intend to take further steps to rectify these material weaknesses, subject to the availability of working capital to fund the costs thereof.

 

Changes in Internal Controls Over Financial Reporting

 

There were no changes in our internal controls over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

20

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

In addition to legal proceedings previously reported in our Annual Report on Form 10-K for the year ended December 31, 2020, from time to time, we may become party to litigation or other legal proceedings that we consider to be a part of the ordinary course of our business. 

 

Item 1A. Risk Factors.

 

As a “smaller reporting company,” we are not required to provide the information required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

In March 2021, the Company sold an aggregate of 200,000 units (the “Units”) in a private offering to two “accredited investors” at a price of $0.50 per Unit. Each Unit consists of (a) two shares of common stock; and (b) one warrant, entitling the holder to purchase one share of our common stock at an exercise price of $0.50 at any time through August 31, 2025.

 

The Company paid a FINRA-member firm a commission of $10,000 and a non-accountable expense fee of $3,000 with respect to the offer and sale of the Units.

 

The securities issued and sold in the March 2021 private offering were issued pursuant to the exemption from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended and/or Rule 506(c) of Regulation D thereunder.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

21

 

 

Item 6. Exhibits.

 

Exhibit
Number
  Description of Exhibit
31.1*   Section 302 Certification of CEO pursuant to Rules 13a - 14(a) or Rule 15d - 14a under the Exchange Act
     
31.2*   Section 302 Certification of CFO pursuant to Rule 13a-14(a) or Rules 15d - 14a under the Exchange Act
     
32.1**   Section 906 Certification of CEO pursuant to Rules 13a - 14(b) or 15d - 14(b) under the Exchange Act and 18 USC 1350
     
32.2**   Section 906 Certification of CFO pursuant to Rules 13a - 14(b) or 15d - 14(b) under the Exchange Act and 18 USC 1350
     
101.INS*   XBRL Instance Document
     
101.SCH*   XBRL Taxonomy Extension Schema Document
     
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document

 

  * Filed herewith

  ** Furnished herewith

 

22

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  VERITAS FARMS, INC.
   
Dated: May 24, 2021 By:  /s/ Stephen E. Johnson
    Stephen E. Johnson, Chief Executive Officer
    (Principal Executive Officer)
     
Dated: May 24, 2021 By: /s/ Michael Pelletier
    Michael Pelletier, Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

23